Neurology Updates

A meta-analysis comparing placebo-controlled trials in MG found a comparable effect of all innovative approaches, except for Rituximab, on the MG-ADL,…

This study explored the link between the evolution of consciousness and the advancement of the decannulation protocol in patients with prolonged…

Updated approach to GBS highlight its complexity and the need for broader approaches and personalized treatments to improve outcomes globally.

This is a summary of the paper titled “Trigeminal ganglion neurons are directly activated by influx of CSF solutes in a migraine model,” published in…

This paper explores the potential connection between hypocretin/orexin neurons in the lateral hypothalamus and epileptic seizures. To investigate this…

Biomarkers are currently rarely used as primary endpoint in clinical trials in neuromuscular diseases. Biomarkers can be divided into…

This open-label controlled study investigates the use of subcutaneous apomorphine for patients with prolonged disorders of consciousness. It suggests…

MS progression is linked to factors like vitamin D, EBV, obesity, and smoking. Targeting these with personalised care may slow progression and improve…

Neurological health disparities, driven by socioeconomic, racial and care inequities, impact outcomes in neurological diseases. Addressing these needs…

Recent advances in stroke prevention highlight the importance of carotid plaque characteristics beyond stenosis degree. The new Plaque-RADS…

This Neurology Update is focused on Amyloid-Related Imaging Abnormalities (ARIA). ARIA refers to a group of brain imaging abnormalities that may be…

Exciting breakthrough in autoimmune vitamin B12 central deficiency: Identification of anti-CD320 autoantibodies targeting a crucial B12 uptake…